• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

荷兰东部基于人群的研究:不同治疗策略治疗乳腺导管原位癌后的局部复发情况

Local recurrences after different treatment strategies for ductal carcinoma in situ of the breast: a population-based study in the East Netherlands.

作者信息

Schouten van der Velden Arjan P, van Vugt Roel, Van Dijck Jos A A M, Leer Jan Willem H, Wobbes Theo

机构信息

Department of Surgical Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.

出版信息

Int J Radiat Oncol Biol Phys. 2007 Nov 1;69(3):703-10. doi: 10.1016/j.ijrobp.2007.03.062. Epub 2007 Jun 4.

DOI:10.1016/j.ijrobp.2007.03.062
PMID:17544591
Abstract

PURPOSE

Outcomes after different treatment strategies for ductal carcinoma in situ (DCIS) of the breast were analyzed for a geographically defined population in the East Netherlands.

METHODS AND MATERIALS

A total of 798 patients with a first diagnosis of DCIS between January 1989 and December 2003 were included and their medical records were reviewed. Survival rates for ipsilateral recurrences were calculated by the Kaplan-Meier method and a multivariate Cox proportional hazards regression model was used to evaluate the prognostic significance of different variables.

RESULTS

The 5-year recurrence-free survival was 75% for breast conserving surgery (BCS) alone (237 patients) compared with 91% for BCS followed by radiation therapy (RT; 153 patients) and 99% for mastectomy (408 patients, p < 0.01). Independent risk factors for local recurrences were treatment strategy, symptomatically detected DCIS, and presence of comedo necrosis. Margin status reached statistical significance only for patients treated by BCS (hazard ratio, 2.0; 95% confidence interval, 1.1-4.0) whereas significance of other prognostic variables did not change.

CONCLUSIONS

In a defined population outside a trial setting, RT after BCS for DCIS lowered recurrence rates. Besides the use of RT, a microscopically complete excision of DCIS is essential. This is especially true for patients with symptomatically detected DCIS and with tumors that contain comedo necrosis, as these groups are at particular high risk for recurrent disease.

摘要

目的

分析荷兰东部某一地理区域内,针对乳腺导管原位癌(DCIS)采用不同治疗策略后的治疗结果。

方法与材料

纳入1989年1月至2003年12月期间首次诊断为DCIS的798例患者,并对其病历进行回顾。采用Kaplan-Meier法计算同侧复发的生存率,并使用多变量Cox比例风险回归模型评估不同变量的预后意义。

结果

单纯保乳手术(BCS)组(237例患者)的5年无复发生存率为75%,而BCS后加放疗(RT;153例患者)组为91%,乳房切除术组(408例患者)为99%(p<0.01)。局部复发的独立危险因素为治疗策略、有症状检出的DCIS以及粉刺样坏死的存在。仅对于接受BCS治疗的患者,切缘状态具有统计学意义(风险比,2.0;95%置信区间,1.1 - 4.0),而其他预后变量的意义未改变。

结论

在非试验环境下的特定人群中,DCIS患者BCS后加RT可降低复发率。除了使用RT外,对DCIS进行显微镜下完整切除至关重要。对于有症状检出的DCIS患者以及含有粉刺样坏死的肿瘤患者尤其如此,因为这些人群复发疾病的风险特别高。

相似文献

1
Local recurrences after different treatment strategies for ductal carcinoma in situ of the breast: a population-based study in the East Netherlands.荷兰东部基于人群的研究:不同治疗策略治疗乳腺导管原位癌后的局部复发情况
Int J Radiat Oncol Biol Phys. 2007 Nov 1;69(3):703-10. doi: 10.1016/j.ijrobp.2007.03.062. Epub 2007 Jun 4.
2
Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.经乳房钼靶检查发现、临床隐匿的导管原位癌,采用保乳手术及根治性乳房放疗进行治疗。
Cancer J Sci Am. 1996 May-Jun;2(3):158-65.
3
Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.接受保乳治疗或乳房切除术的乳腺导管原位癌患者局部复发及特定病因生存率的相关因素。
Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1514-21. doi: 10.1016/j.ijrobp.2005.04.045. Epub 2005 Jul 11.
4
Local recurrences after conservative treatment of ductal carcinoma-in-situ of the breast without radiotherapy: the effect of age.未经放疗的乳腺导管原位癌保守治疗后的局部复发:年龄的影响
Ann Surg Oncol. 2006 Jul;13(7):990-8. doi: 10.1245/ASO.2006.05.044. Epub 2006 May 22.
5
259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.应用USC/范纽斯预后指数的259例乳腺导管原位癌患者:长期随访的回顾性研究
Breast Cancer Res Treat. 2008 Jun;109(3):405-16. doi: 10.1007/s10549-007-9668-7. Epub 2007 Aug 9.
6
Clinical outcome after selective treatment of patients diagnosed with ductal carcinoma in situ of the breast.对诊断为乳腺导管原位癌的患者进行选择性治疗后的临床结果。
Ann Surg Oncol. 2008 Jan;15(1):235-43. doi: 10.1245/s10434-007-9659-2. Epub 2007 Nov 7.
7
The frequency of ipsilateral second tumors after breast-conserving surgery for DCIS: a population based analysis.DCIS保乳手术后同侧第二原发肿瘤的发生率:一项基于人群的分析。
Cancer. 2005 Nov 1;104(9):1840-8. doi: 10.1002/cncr.21406.
8
Outcomes and factors impacting local recurrence of ductal carcinoma in situ.导管原位癌局部复发的结局及影响因素。
Cancer. 2000 Apr 1;88(7):1643-9.
9
Feasibility of breast-conserving surgery for patients with breast carcinoma associated with nipple discharge.乳头溢液相关乳腺癌患者保乳手术的可行性
Cancer. 2004 Aug 1;101(3):508-17. doi: 10.1002/cncr.20394.
10
Salvage treatment for local recurrence after breast-conserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ of the breast.保乳手术和放疗作为乳腺钼靶检测到的乳腺导管原位癌的初始治疗后局部复发的挽救性治疗。
Cancer. 2001 Mar 15;91(6):1090-7.

引用本文的文献

1
Relationship Between Anthropometric Factors and Risk of Second Breast Cancer Among Women With a History of Ductal Carcinoma In Situ.原位导管癌病史女性的人体测量学因素与二次乳腺癌风险之间的关系
JNCI Cancer Spectr. 2018 May 30;2(2):pky020. doi: 10.1093/jncics/pky020. eCollection 2018 Apr.
2
Advances in Breast MRI in the Setting of Ductal Carcinoma In Situ.导管原位癌背景下乳腺磁共振成像的进展
Semin Roentgenol. 2018 Oct;53(4):261-269. doi: 10.1053/j.ro.2018.08.006. Epub 2018 Aug 30.
3
Evaluating the efficacy of post-surgery adjuvant therapies used for ductal carcinoma patients: a network meta-analysis.
评估用于导管癌患者的术后辅助治疗的疗效:一项网状Meta分析。
Oncotarget. 2017 Apr 21;8(45):79257-79269. doi: 10.18632/oncotarget.17366. eCollection 2017 Oct 3.
4
Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women.导管原位癌治疗后同侧和对侧浸润性乳腺癌的后续风险:10,090名女性人群队列中的发病率及放疗效果
Breast Cancer Res Treat. 2016 Oct;159(3):553-63. doi: 10.1007/s10549-016-3973-y. Epub 2016 Sep 8.
5
Lobular carcinoma in situ (LCIS) of the breast: is long-term outcome similar to ductal carcinoma in situ (DCIS)? Analysis of 200 cases.乳腺小叶原位癌(LCIS):其长期预后与导管原位癌(DCIS)相似吗?200例病例分析。
Radiat Oncol. 2015 May 6;10:110. doi: 10.1186/s13014-015-0379-7.
6
Ductal Carcinoma In Situ of the Breast: Evaluating the Role of Radiation Therapy in the Management and Attempts to Identify Low-risk Patients.乳腺导管原位癌:评估放射治疗在管理中的作用及识别低风险患者的尝试
Am J Clin Oncol. 2015 Oct;38(5):526-33. doi: 10.1097/COC.0000000000000102.
7
Disease-free survival by treatment after a DCIS diagnosis in a population-based cohort study.基于人群队列研究的 DCIS 诊断后治疗的无病生存。
Breast Cancer Res Treat. 2013 Aug;141(1):145-54. doi: 10.1007/s10549-013-2670-3. Epub 2013 Aug 25.
8
Incidence and consequence of close margins in patients with ductal carcinoma-in situ treated with mastectomy: is further therapy warranted?保乳手术治疗导管原位癌患者切缘近切缘的发生率和后果:是否需要进一步治疗?
Ann Surg Oncol. 2013 Dec;20(13):4103-12. doi: 10.1245/s10434-013-3194-0. Epub 2013 Aug 23.
9
Conservative treatment of breast ductal carcinoma in situ: results of an Italian multi-institutional retrospective study.乳腺导管原位癌的保守治疗:意大利多机构回顾性研究结果。
Radiat Oncol. 2012 Oct 25;7:177. doi: 10.1186/1748-717X-7-177.
10
Is there a role for postmastectomy radiation therapy in ductal carcinoma in situ?保乳术后放疗在导管原位癌中是否有作用?
Int J Surg Oncol. 2012;2012:423520. doi: 10.1155/2012/423520. Epub 2012 Jun 13.